The earnings release came a day after Alexion (ticker: ALXN) announced a $1.4 billion deal to acquire Portola Pharmaceuticals (PTLA), which sells a medicine used to stop serious bleeding in patients who have been given certain anticoagulant medications.Write to Josh Nathan-Kazis at josh.nathan-kazis@barrons.com Shares of Alexion Pharmaceuticals dropped Wednesday morning after the company reported first-quarter earnings that beat Wall Street expectations but lowered its revenue guidance because of the Covid-19 pandemic.